• ISSN 2399-1623
Danladi B Adamu, Nicole Robertson, David Weller, and Christine Campbell



Sub-Saharan Africa (SSA) accounts for about 70% of the global burden of cervical cancer; this is due to several factors including lack of access to cervical cancer screening, low knowledge of cervical cancer and screening services, poor-functioning health systems, insufficient and poorly trained health workers, and the high burden of human immunodefiency virus (HIV) infection. To date, to the best of our knowledge, there has been no systematic review of the literature on the role of community-based resources such as community health workers and community-based organisations in increasing the uptake and or continuing participation of women in cervical cancer screening, in the setting of high HIV burden, in sub-Saharan Africa.


We will systematically search selected databases and websites from 1980 to date for published and grey literature including citation and reference list tracking, on studies with a community focus carried out in sub-Saharan Africa, without language restrictions. Randomised controlled trials (RCTs), observational studies, and qualitative and mixed methods studies of interventions (carried out with and without comparison groups) reporting impact on participation in cervical cancer screening in sub-Saharan Africa will be identified and assessed for methodological quality by two independent reviewers. We will use narrative synthesis and/or meta-analysis depending on the study selection.


Findings will be summarised into abstracts for presentation at conferences and submission to peer-reviewed journals in the field for wide-ranging dissemination to patients, researchers, healthcare professionals and policy makers on cervical cancer in sub-Saharan Africa.


The review will address the gap in evidence for effective and implementable community-based strategies that encourages uptake of cervical cancer screening among women living in sub-Saharan Africa. The findings will have the potential to inform future screening practice and research with the hope of reducing the burden of cervical cancer in the region.


registration number – CRD42018102539.

Cervical cancer (CC) is a preventable public health problem that affects women worldwide. The highest burden of the disease is found in Sub-Saharan Africa (1). In this study, we refer to SSA as a region in Africa that includes 48 countries according to the World Bank classification (2). According to the latest 2018 Globocan estimates for cervical cancer rates, Swaziland has the highest age standardised incidence rates of about 75 per 100,000 women per year while Malawi have the highest age standardised mortality of about 54 per 100,000 women per year in the world respectively (1). The high mortality and morbidity of CC in SSA can be attributed to the lack of national cancer prevention programmes and limited resource allocation to the prevention and treatment of CC precancerous lesions (3). Overall, the main risk factor for CC is persistent or chronic infection of the cervix by one or more types of oncogenic or high risk human papilloma viruses (HPV) with serotypes 16 and 18 accounting for as much as 70% of cases of CC around the world. (4). HPV is the most common infection acquired during sexual intercourse, usually early in sexual history, but HPV alone cannot explain the high incidence of the disease – hence, a number of associated co-risk factors have been identified. These include HIV infection, multiparity, multiple sexual partners, early sexual exposure, low socioeconomic status, smoking, use of oral contraceptives for over five years and co-infection with other sexually transmitted agents, such as those that cause herpes simplex, chlamydia and gonorrhoea, (5). HIV compromises the immune system, making women more susceptible to HPV infection (6). Indeed, the association of CC and HIV/AIDS was identified more than two decades ago (7).

Given the high burden of CC in SSA and the inadequate allocation of resources, advocacy and political attention to its control in the region (3, 8). There is a need for alternative strategies to reduce the burden of CC and the disparity between high income countries (HICS) and low and middle income countries (LMICs) (9). Systematic reviews of the reasons for low CC screening uptake in SSA by Lim and Ojo (10), Randall and Ghebre (11), Maseko et al (12) and McFarland et al. (13) found fear, low level of awareness, embarrassment and invasion of privacy, lack of spousal support, cost, distance to screening facility, long waiting time and attitude of health workers to be the reasons discouraging SSA women from attending for CC screening. They identified some evidence gaps in areas including: overcoming cultural beliefs and practices, the role of men and religious leaders, and low level of awareness and knowledge of CC screening services. They suggest strategies to address some of these gaps should include use of community-based resources and members to provide culturally sensitive innovations.

Approaches to increase uptake of cervical cancer screening

A number of innovations have been studied to increase uptake of CC screening among women with limited access, including women in SSA and other regions of the world. Systematic reviews (14-18) have examined the effect of different interventions at overcoming barriers to uptake of CC screening among ethnic minorities and women with limited knowledge worldwide. Interventions examined include CC education, provider recommendations and use of local health assistants. A recent systematic review (15), showed that a theory-based CC educational intervention significantly increased CC screening rates by more than twice (OR=2.46; 95%CI: 1.88-3.21) and offering women self-sampling for HPV testing also increased CC screening rates (OR=1.71; 95%CI: 1.32-2.22) compared to controls; the review also noted a significant effect on uptake of CC screening of invitation letters, making appointments and sending reminders to women due or over-due for screening. Innovations involving the use of community members to overcome cultural feelings and to provide culturally harmonised communications have increased success of screening among women outside of SSA (19, 20). To inform the development of culturally suitable community-level cervical cancer screening for women in SSA, our systematic review will concentrate on evidence of implementation and effectiveness of community-based resources such as community health workers and or community-based civil society organisations in supporting CC screening in SSA.

Community Health Workers (CHWs)

CHWs are a category of health workers that mainly work in the community outside of health facilities; they usually have a relationship with their community, such as common language, ethnicity, race, geography, or disease condition (21). The work, cadre and efficacy of CHWs differ from country to country - and within countries, from one region to another. The World Health Organization (WHO) has defined CHWs as people who work in health care and services-related fields and have training specific to and for the purpose of their job or intervention - they have no formal professional or paraprofessional certificate or tertiary degree education. The WHO recommends that CHWs should be members of the community where they work, chosen by the community and accountable to the community – whereby they are supported by the health system, but not necessarily part of it (22). The WHO recommended a task-shifting approach to purpose-trained lay or volunteer workers (eg, CHWs) from professional health workers (eg, nurses and doctors) in order to compensate for the shortage of manpower deficit and other health care services in developing countries; this approach will help in filling the gap and reduce time to scale-up of manpower (23). Task-shifting to non-physician health workers (NPHWs) was found to be an effective and reasonable innovation to increase access to cancer care in LMICs (24).

CHWs played a remarkable role in controlling the recent Ebola outbreak in Guinea, Liberia and Sierra Leone and the implementation of MDGs and achieving Universal Health Coverage in WHO Africa region (22). They have supported HIV, malaria and pneumonia and tuberculosis prevention and treatment in SSA (25). Table 1 describes some of the different names and cadres of CHWs in use in SSA.

Table 1.  Labels of CHWs in Sub-Saharan Africa (adapted from (21, 25))
Country Name of CHWs Number
Ethiopia Health Development Army Team (HAD) >94,000
Health Extension Workers (HEW) >34,000
Peer Counsellors (PC) -
Gambia Community Health Workers 1150
Ghana Community Based Agents 16,800
Kenya Community Health Volunteers 4,725
Community Health Workers -
Community Care Coordinators -
Lesotho Lay Health Workers -
Malawi Health Surveillance Assistants 10,500
Community Volunteers -
Home Based Care Volunteers -
Lay Counsellors -
Mali Agent de Santé Communautaire 2052
Mozambique Agentes Polivalentes Elementares 2726
Community Health Workers -
Niger Agent de Santé Communautaire 2,560
Nigeria Community Health Workers -
Community Health Extension Workers -
Village Health Workers 86,000
Rwanda Village Health Workers 60,000
Community Health Workers -
South Africa Home Based Carer (HBC) 47,121
Lay Counsellors (LC) 9,243
Adherence Counsellor (AC) 2,010
Directly Observed Therapy Supporter for TB (DOTS) 2,740
Peer Educator (PE) 1,810
Patient Advocates -
Uganda Village Health Teams (VHT) 83,396
Peer Health Workers -
Lay Community Volunteers -
Zambia Community Health Volunteer (CHV) 23,400
Community Health Assistant (CHA) 600
Lay Counsellors and Health Workers -
Adherents Supporters -
Other Cadres of CHW in SSA includes Health Volunteers; Health Aides; Health Supporters; Health Guides; Peer Navigators; Patient Navigators; Promotora. -

CHW – community health worker, SSA – sub-Saharan Africa

Community-based Organisations (CBOs)

Community based organisations such as non-governmental civil society organisations (CSOs) include: faith based organisations (FBOs) eg, churches; womens’ organisations; health facility committees; village or ward development committee (VDC or WDC); rotary clubs; social clubs; academic and professional institutions and organisations; students’ unions; foundations and philanthropies. The role of non-governmental civil society organisations (CSOs) and individuals in the community in supporting cancer control efforts was emphasised by Brawley et al. (26); these organisations support health care providers by providing training, equipment and supplies, advocacy and education to the public. They collaborate with governments and businesses to support and catalyse national cancer control in low and medium income countries; CSOs are more acceptable in some settings than governmental organisations and are more likely to provide culturally appropriate support to overcome barriers and attitudes to screening because of their cultural understanding of groups targeted for screening.

For over a decade, The Alliance for Cervical Cancer Prevention (ACCP) has demonstrated significant success, building partnerships and learning from a number of community based organisations in SSA about identifying effective ways to increase women’s voluntary participation in screening programs. For example, 1) in Kenya, they partnered with “Maendeleo Ya Wanawake Organization”, a national grassroots women’s organization with an estimated individual membership of 2 million women and more than 25,000 women’s groups, 2) in Ghana, they partnered with a local Rotary International Club and 3) with Khayelitsha Settlement in South Africa (27-29). Engagement of faith-based groups led to a reported increase in uptake of CC screening, knowledge of CC and positive change of behaviour towards CC screening among African American and Somali American women in the US (30, 31).


In all systematic reviews on strategies to increase uptake of CC screening we have found, none have focused on our particular target groups and interventions – that is, examining the implementation and effectiveness of community level structures and services such as CHWs and or CBOs on CC screening among women in SSA (living with and without HIV). The review with most similarities to ours described efforts to integrate CC screening with HIV services in order to improve uptake of screening in SSA, finding that routine provision is still not adequate (32). This review will examine literature for SSA; although CHWs and CBOs are involved in supporting health care delivery in different contexts around the world, we choose to restrict our geographical coverage to SSA to ensure that findings are of immediate applicability in our target population.

Review question

What are the evidence of implementation and effectiveness of community health workers and or community-based organisations at increasing uptake of and/or continuing participation in CC screening among women in SSA?

Study objective

To explore and assess the implementation and effectiveness of community health workers and or community-based organisations in increasing uptake and or continuing participation in cervical cancer screening among women in sub-Saharan Africa.


The development and reporting of this protocol was guided by the Preferred Reporting Items for Systematic Review and Meta-analyses Protocols (PRISMA-P) statement (33), the Centre for Reviews and Dissemination (CRD) (34) and the Cochrane Handbook for Systematic Reviews of Intervention (35).

Eligibility criteria

This criteria is guided by the PICOS (Problem or Population, Interventions, Comparisons or Control, Outcome and Study design) framework (36, 37).


Included participants: Our target group are women eligible for CC screening in SSA. They are:

  1. Women of reproductive age group (18-49 years) and older women (50 years and older) either HIV negative or HIV positive.

  2. Women with prior normal screening results or schedule for follow-up screening.

  3. Women due or overdue for screening in various settings such as screening programs and outreaches, HIV clinics, community health centres and sexual and reproductive health services.

Excluded participants: Women who:

  1. Have had a hysterectomy.

  2. Were treated or are in follow-up care for cervical cancer.

  3. Are pregnant

  4. Are younger than 18 years.

  5. Are living outside sub-Saharan Africa.


The interventions are services offered by community health workers and or community-based organisations in SSA.


We will consider studies with and without control groups. The control groups will be women who either receive no intervention, or routine standard screening services.

Outcome measures

Primary outcome measure: This is the reported uptake of CC screening and/or continuing participation, as a result of interventions based on community health workers and or community-based organisations in sub-Saharan Africa.

Secondary outcome measures: These are the reported: barriers to and facilitators of CC screening; increase in knowledge of CC and screening; acceptability and satisfaction with CC screening method or screening program aided or led by CHWs and or CBOs, accessibility to CC screening programmes or facilities and costs of screening interventions.

Studies design

We anticipate varying study designs including RCTs, and observational, qualitative and mixed-methods studies. Due to the challenges and high cost of conducting RCTs in SSA, we anticipate finding mainly non-RCTs, including cohort studies, case-control studies, and controlled before and after studies from SSA. We are aware that inclusion of non-RCTs might compromise the validity of recommendations and robustness of the review, but they will be subjected to rigorous quality assessment. Further, although, RCTs are the optimal study design for review of implementation and effectiveness of interventions, reliance solely on RCTs may mean missing important data in challenging settings such as SSA.

For studies including cancers/diseases other than CC, or conducted in both SSA and non-SSA countries, we will take all possible steps to extract results specific to CC and SSA - and, where possible, contact study authors for further information. Conference abstracts where we are unable to find full text will be excluded as they typically don’t provide sufficient data for analysis. No restriction of language will be imposed. The most affordable CC screening method in SSA is VIA or VILI. If, however, we identify interventions aimed at increasing uptake of other CC screening methods (including HPV DNA testing, cytology/pap smear), we will consider them for inclusion.

Search methods

The PICO (Problem or Population, Interventions, Comparison and Outcome) framework will be used in developing the search strategy and identifying relevant studies. (35). Published, unpublished and grey literature in all languages will be searched and translations will be carried out when necessary. The search strategy will be developed in collaboration with a medical librarian. Medical Subject Heading (MeSH) and free text terms will be developed and combined to identify published studies on MEDLINE via OVID interface, the search strategy will then be adapted for EMBASE, Global Health, CINAHL, ASSIA, PsycINFO, Web of science, Cochrane Central Register of Controlled Trials (CENTRAL) and Google Scholar (first 500 results). Truncation commands (using root words to capture alternative word endings), proximity operators (for words within a chosen distance of each other) and Boolean logic operators (OR and AND) will be used, and to ensure maximum yield, preliminary trial with search terms will be conducted and refined.

We will search African regional databases including African Index Medicus (AIM), African journal online (AJOL) and African Organisation for research and training in cancer (AORTIC), Open Grey and ProQuest Dissertations and Theses Global databases will be searched for more published, unpublished and grey literature.

Additional papers will be located through hand-searching of citations and reference list tracking, and contacts with authors and experts in the field for further information. A PRISMA flow chart diagram (Figure1) will be used to summarise the search and selection strategies (38). Our search strategy for identifying studies on MEDLINE database is presented in Table 2.

Figure 1.  PRISMA flow diagram.

Table 2.  MEDLINE Search Strategy via OVID
1. Uterine Cervical Neoplasms/
2. Cervix Uteri/ or Uterine Cervical Dysplasia/ or Cervical Intraepithelial Neoplasia/
3. Carcinoma in situ/ or adenocarcinoma in situ/
4. (cervi$ or uter$ or cancer$ or carcinom$ or precancer$ or premalignan$ or CIN$ or SIL$ or disease$ or lesion$ or grad$).mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]
5. 1 or 2 or 3 or 4
6. Early diagnosis/ or "early detection of cancer"/
7. Mass Screening/
8. Visual inspection with acetic acid.mp.
9. Visual inspection with lugols iodine.mp.
10. VIA.mp.
11. VILI.mp.
12. Papanicolaou Test/
13. HPV self-testing.mp.
14. HPV DNA test.mp. or Human Papillomavirus DNA Tests/
15. Cervical cytology.mp. or Vaginal Smears/
16. Colposcopy.mp. or COLPOSCOPY/
17. HIV Infections/ or Acquired Immunodeficiency Syndrome/ or HIV Seropositivity/
18. Self-Examination/
19. "Patient Acceptance of Health Care"/ or Self Care/ or self-test.mp.
20. (screen* or detect* or cytolog* or smear* or test* or self-test* or self-exam* or self-sampl* or self-collect*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]
21. 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20
22. (intervention* or strateg* or approach* or innovat* or barrier* or communit* or communit* or uptake* or increase* or overcome* or continu* or participa* or adhere*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]
23. Community Health Workers/
24. Volunteers/
25. Community Health extension worker.mp.
26. Peer Group/ or Peer Educator.mp. or Health Education/
27. Counselling/ or Peer Counsellors.mp.
28. Peer Health Workers.mp.
29. Patient Navigation/ or peer navigator.mp.
30. Patient Advocacy/ or Patient Advocates.mp.
31. Community Care Coordinators.mp.
32. Lay Health Workers.mp.
33. Health Surveillance Assistants.mp.
34. Caregivers/
35. Agentes Polivalentes Elementares.mp.
36. Agent de Santé Communautaire.mp.
37. Adherence Counsellor.mp.
38. Community Health Services/ or Community Based Agents.mp.
39. Organizations/ or charities/ or faith-based organizations/ or labor unions/ or self-help groups/ or societies/
40. Health facility committees.mp.
41. Women groups.mp. or Women/
42. religion/ or Christianity/ or Islam/ or "religion and medicine"/
43. Community Participation/ or ward development committee.mp.
44. Rural Health Services/ or village development committee.mp.
45. Telephone/ or phone calls.mp. or Cell Phone/
46. Cell phone/ or text messaging/
47. Reminder Systems/ or reminder letter.mp.
48. Health Education/ or cancer education.mp. or Health Knowledge, Attitudes, Practice/
49. (imam* or pastor* or shiek* or bishop* or reverend* or mosque* or church*).mp. [mp=title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms]
50. 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49
52. 5 and 21 and 50 and 51
53. limit 52 to yr="1980 -Current"
54. limit 53 to humans

Data collection and analysis

Selection of studies

All titles and abstracts of studies identified by electronic database searches will be saved in EndNote library, after screening for duplicates, the remaining titles and abstracts will be reviewed independently by two reviewers. Full text copies will be downloaded and two reviewers will independently assess the studies for eligibility of inclusion into the review and disagreements will be resolved by discussion, 10% of the selected studies will be checked by 3rd reviewer for consistency. The reasons for exclusion of those studies screened in full text will be documented.

Data extraction

Two reviewers will independently extract the data from included studies using defined data extraction forms and differences between reviewers will be resolved by discussion and mutual agreement. Key characteristics of the studies (including primary outcomes) and secondary outcomes of the review will be recorded on separate tables.

The key characteristics to be extracted include:

  1. Author, publication year and funding source.

  2. Journal citation (including language).

  3. Period of study (by year)

  4. Country of study/study setting.

  5. Study design.

  6. Study population (characteristics and total number enrolled).

  7. Intervention details (types of intervention, role of intervention, duration of intervention; duration of follow-up); primary outcomes including descriptive statistics, odds ratio (OR) or risk ratio (RR).

Quality assessment

In this review, we will adapt and use the quality assessment tools as shown in Table3. We plan to report in narrative form and tables the results of methodological assessments of each individual study, the overall quality of the entire set of included studies cannot be merged together due to variation in tools and assessment methods. Our aim will be to exclude studies with very low scores based on distribution of quality scores especially outliers. Disagreements that arise between the reviewers will be resolved through discussion.

Table 3.  Quality assessment tools
Tools Study designs
EPHPP tools Randomised controlled trials.
Cohort studies (eg, two group pre and post; one group pre and post; before and after)
Case-control studies
Controlled clinical trials
Cross-sectional studies
Interrupted time series studies
Other non-randomised studies of intervention
CASP checklist Qualitative studies (eg, focused group discussions, interviews)
MMAT tools Mixed methods studies

EPHPP – effective public health practice project, CASP – critical appraisal skills programme, MMT – mixed-methods appraisal tool

Data synthesis

We anticipate that meta-analysis will not be the appropriate method of data synthesis due to heterogeneous nature of the study designs – therefore, we will conduct a narrative synthesis of data from included studies according to (25, 39, 40).

For any data we are able to synthesise through meta-analysis, we may consider a subgroup analysis based on vehicles for delivery of interventions (eg, CHWs or CBOs) or target groups (eg, HIV positive and HIV negative women). This will allow us to report the summary effects computed within subgroups, and, if possible, compare the summary effects computed in diverse subgroups. Statistical pooling of the effect of individual studies will be undertaken using RevMan 5.3, Review Manager Software.

Odds Ratios (OR) and a random-effects model will be used for meta-analysis (41). We will assess heterogeneity between studies using Higgin’s I2 statistic. Publication bias in the included studies in meta-analysis will be assessed using Funnel plots to be generated by RevMan 5.3 software (42). GRADE will be used to assess the strength of the body of evidence.

Ethics and dissemination.

Ethical issues – This study does not require ethical approval as only secondary data from published and grey sources will be assessed.

Publication plan – The systematic review protocol is registered with PROSPERO, registration number: CRD42018102539. Results of the review will be presented in conferences and submitted to peer-reviewed journal for extensive reach out to patients, researchers, healthcare professionals and policy makers on cervical cancer in sub-Saharan Africa.


This review is the first component of a project that is intended to inform a culturally acceptable community level cervical cancer screening programme in sub-Saharan Africa. The study will provide an understanding of the role of community members in supporting CC screening in their communities. It is the first review to our knowledge on the role of community health workers and community-based organisations in increasing CC screening in SSA.


We thank Marshall Dozier at the University of Edinburgh for guidance on search of database and strategy, and for agreeing to review this protocol.


[1] Financial disclosure Funding: This review is part of PhD study funded by Commonwealth Scholarship Commission. The Commission had no role in preparation, funding and decision to publish this protocol.

[2] Conflicts of interest Competing interest: The authors completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available upon request from the corresponding author), and declare no conflicts of interest..


1F Bray, J Ferlay, I Soerjomataram, RL Siegel, LA Torre, and A Jemal. . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. C CA Cancer J Clin. 2018;68:p.394–424. DOI: 10.3322/caac.21492. [30207593]

2The World Bank. The World Bank Country and Lending Groups. Country Classafications. Available: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519. Accessed: 7 May 2018.

3L Bradford and A Goodman. . Cervical cancer screening and prevention in low-resource settings. Clin Obstet Gynecol. 2013;56(1):p.76–87. DOI: 10.1097/GRF.0b013e31828237ac. [23337844]

4G Clifford, S Franceschi, M Diaz, N Muñoz, and LL Villa. . Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine. 2006;24 Supplement 3:p.S3–34. DOI: 10.1016/j.vaccine.2006.05.026. [16950015]

5World Health Organization. Comprehensive cervical cancer control: a guide to essential practice – 2nd ed. Geneva: World Health Organization; 2014.

6AJ Sasco, A Jaquet, E Boidin, DK Ekouevi, F Thouillot, and T LeMabec. The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa. PLoS One. 2010;5:e8621. DOI: 10.1371/journal.pone.0008621. [20066157]

7Centre for disease control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports. 1992;41(Rr-17):1-19.

8U Samarasekera and R Horton. . Women’s cancers: shining a light on a neglected health inequity. Lancet. 2017;389:p.771–3. DOI: 10.1016/S0140-6736(16)31798-6. [27814968]

9L Denny, S de Sanjose, M Mutebi, BO Anderson, J Kim, and J Jeronimo. Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries. Lancet. 2017;389:p.861–70. DOI: 10.1016/S0140-6736(16)31795-0. [27814963]

10JN Lim and A Ojo. . Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care (Engl). 2017;26(1). Epub 2016 Feb 7. DOI: 10.1111/ecc.12444. [26853214]

11TC Randall and R Ghebre. . Challenges in prevention and care delivery for women with cervical cancer in sub-Saharan Africa. Front Oncol. 2016;6:p.160 . DOI: 10.3389/fonc.2016.00160. [27446806]

12F Chidyaonga-Maseko, ML Chirwa, and AS Muula. . Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors. Pan Afr Med J. 2015;21:p.231 . DOI: 10.11604/pamj.2015.21.231.6350. [26523173]

13DM McFarland, SM Gueldner, and KD Mogobe. . Integrated Review of Barriers to Cervical Cancer Screening in Sub‐Saharan Africa. J Nurs Scholarsh. 2016;48(5):p.490–8. DOI: 10.1111/jnu.12232. [27434871]

14HR Han, J Kim, JE Lee, HK Hedlin, H Song, and Y Song. Interventions that increase use of Pap tests among ethnic minority women: a meta‐analysis. Psychooncology. 2011;20:p.341–51. DOI: 10.1002/pon.1754. [20878847]

15J Musa, CJ Achenbach, LC O’Dwyer, CT Evans, M McHugh, and L Hou. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis. PLoS One. 2017;12(9):e0183924. DOI: 10.1371/journal.pone.0183924. [28873092]

16T Everett, A Bryant, MF Griffin, PPL Martin-Hirsch, CA Forbes, and RG Jepson. . Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev. 2011;5:CD002834. DOI: 10.1002/14651858.CD002834.pub2. [21563135]

17R Albrow, K Blomberg, H Kitchener, L Brabin, J Patnick, and C Tishelman. Interventions to improve cervical cancer screening uptake amongst young women: a systematic review. Acta Oncol. 2014;53:p.445–51. DOI: 10.3109/0284186X.2013.869618. [24660768]

18I Rees, D Jones, H Chen, and U Macleod. . Interventions to improve the uptake of cervical cancer screening among lower socioeconomic groups: A systematic review. Prev Med. 2018;111:p.323–35. DOI: 10.1016/j.ypmed.2017.11.019. [29203349]

19H-R Han, J-E Lee, J Kim, HK Hedlin, H Song, and MT Kim. . A meta-analysis of interventions to promote mammography among ethnic minority women. Nurs Res. 2009;58:p.246–54. DOI: 10.1097/NNR.0b013e3181ac0f7f. [19609176]

20M Lu, S Moritz, D Lorenzetti, L Sykes, S Straus, and H Quan. . A systematic review of interventions to increase breast and cervical cancer screening uptake among Asian women. BMC Public Health. 2012;12:p.413 . DOI: 10.1186/1471-2458-12-413. [22676147]

21HB Perry, R Zulliger, and MM Rogers. . Community health workers in low-, middle-, and high-income countries: an overview of their history, recent evolution, and current effectiveness. Annu Rev Public Health. 2014;35:p.399–421. DOI: 10.1146/annurev-publhealth-032013-182354. [24387091]

22World Health Organization. Community Health Worker Programmes In The WHO African Region: Evidence and Options — Policy Brief. Geneva: World Health Organization; 2017.

23A Olaniran, H Smith, R Unkels, S Bar-Zeev, and N van den Broek. . Who is a community health worker?–a systematic review of definitions. Glob Health Action. 2017;10:1272223. DOI: 10.1080/16549716.2017.1272223. [28222653]

24R Joshi, M Alim, AP Kengne, S Jan, PK Maulik, and D Peiris. Task shifting for non-communicable disease management in low and middle income countries - a systematic review. PLoS One. 2014;9:e103754. DOI: 10.1371/journal.pone.0103754. [25121789]

25GW Mwai, G Mburu, K Torpey, P Frost, N Ford, and J Seeley. . Role and outcomes of community health workers in HIV care in sub‐Saharan Africa: A systematic review. J Int AIDS Soc. 2013;16:p.18586 . DOI: 10.7448/IAS.16.1.18586. [24029015]

26OW Brawley and SG Cowal. . Civil society’s role in efforts to control women’s cancers. Lancet. 2017;389:p.775–6. DOI: 10.1016/S0140-6736(16)31799-8. [27814966]

27I Agurto, S Arrossi, S White, P Coffey, I Dzuba, and A Bingham. Involving the community in cervical cancer prevention programs. Int J Gynaecol Obstet. 2005;89 Suppl 2:p.S38–45. DOI: 10.1016/j.ijgo.2005.01.015. [15823265]

28Alliance for Cervical Cancer Prevention. Recent Evidence on Cervical Cancer Screening in Low-Resource Settings. Alliance for Cervical Cancer Prevention, Factsheet.May 2011.

29Alliance for Cervical Cancer Prevention. New evidence on the impact of cervical cancer screening and treatment using HPV DNA tests, visual inspection, or cytology. Alliance for Cervical Cancer Prevention, Factsheet. July 2009.

30AK Matthews, N Berrios, JS Darnell, and E Calhoun. . A qualitative evaluation of a faith-based breast and cervical cancer screening intervention for African American women. Health Educ Behav. 2006;33:p.643–63. DOI: 10.1177/1090198106288498. [16861590]

31R Pratt, S Mohamed, W Dirie, N Ahmed, M VanKeulen, and H Ahmed. Views of Somali women and men on the use of faith-based messages promoting breast and cervical cancer screening for Somali women: a focus-group study. BMC Public Health. 2017;17:p.270 . DOI: 10.1186/s12889-017-4182-2. [28320350]

32L Sigfrid, G Murphy, V Haldane, FLH Chuah, SE Ong, and F Cervero-Liceras. Integrating cervical cancer with HIV healthcare services: A systematic review. PLoS One. 2017;12:e0181156. DOI: 10.1371/journal.pone.0181156. [28732037]

33D Moher, L Shamseer, M Clarke, D Ghersi, A Liberati, and M Petticrew. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:p.1 . DOI: 10.1186/2046-4053-4-1. [25554246]

34Centre for Reviews and Dissemination. Systematic Reviews: Centre for Reviews and Dissemination’s guidance for undertaking reviews in health care, University of York. Available: https://www.york.ac.uk/media/crd/Systematic_Reviews.pdf 2009. Accessed: 24 June 2018.

35Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration; 2011. Available from www.cochrane-handbook.org. Accessed: 2 April 2018.

36C Schardt, MB Adams, T Owens, S Keitz, and P Fontelo. . Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak. 2007;7:p.16 . DOI: 10.1186/1472-6947-7-16. [17573961]

37S Aslam and P Emmanuel. . Formulating a researchable question: A critical step for facilitating good clinical research. Indian J Sex Transm Dis AIDS. 2010;31:p.47–50. DOI: 10.4103/0253-7184.69003. [21808439]

38D Moher, A Liberati, J Tetzlaff, and DG Altman. . PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. DOI: 10.1371/journal.pmed.1000097. [19621072]

39Mays N, Pope C, Popay J. Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field. J Health Serv Res Policy.. 2005;10(SI: 1):6-20.

40Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme Version. 2006;1:b92.

41C Tufanaru, Z Munn, M Stephenson, and E Aromataris. . Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness. Int J Evid-Based Healthc. 2015;13:p.196–207. DOI: 10.1097/XEB.0000000000000065. [26355603]

42Manager R. (RevMan) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.